REGENXBIO Inc. (RGNX) financial statements (2021 and earlier)

Company profile

Business Address 9600 BLACKWELL ROAD
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:400471176159216
Cash and cash equivalents7076472554
Short-term investments2272441146560
Other undisclosed cash, cash equivalents, and short-term investments1041511669102
Receivables389012
Prepaid expense66521
Other current assets44111
Other undisclosed current assets(104)(151)(16)(69)(102)
Total current assets:34533816893118
Noncurrent Assets
Operating lease, right-of-use asset10
Property, plant and equipment29291491
Long-term investments and receivables1081741669103
Long-term investments1041511669103
Accounts and financing receivable, after allowance for credit loss423   
Restricted cash and investments1100 
Other noncurrent assets52100
Total noncurrent assets:1532063179103
TOTAL ASSETS:498544199173221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities18151153
Accounts payable64521
Accrued liabilities00001
Employee-related liabilities119631
Taxes payable 1   
Debt2    
Customer advances and deposits  0
Contract with customer, liability1
Other undisclosed current liabilities147451
Total current liabilities:342214104
Noncurrent Liabilities
Long-term debt and lease obligation9    
Operating lease, liability9
Liabilities, other than long-term debt57110
Deferred revenue and credits110
Deferred revenue3
Contract with customer, liability3
Deferred rent credit 1
Other liabilities23   
Other undisclosed noncurrent liabilities 6   
Total noncurrent liabilities:1413110
Total liabilities:483516115
Stockholders' equity
Stockholders' equity attributable to parent450509183162217
Common stock00000
Additional paid in capital628593371276269
Accumulated other comprehensive income (loss)0(1)(1)(0)(1)
Accumulated deficit(178)(83)(188)(115)(52)
Total stockholders' equity:450509183162217
TOTAL LIABILITIES AND EQUITY:498544199173221

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues352191058
Revenue, net1058
Cost of revenue(8)(10)(2)(1)(2)
Cost of goods and services sold(8) (2)(1)(2)
Gross profit:27209946
Operating expenses(176)(121)(84)(69)(29)
Other operating income (expense), net0(0)(0)0 
Other undisclosed operating income 00  
Operating income (loss):(149)88(76)(65)(23)
Nonoperating income5216320
Investment income, nonoperating49732 
Other nonoperating income    0
Interest and debt expense    (0)
Income (loss) from continuing operations before income taxes:(97)104(73)(63)(23)
Income tax expense (benefit)3(4) 0 
Net income (loss):(95)100(73)(63)(23)
Other undisclosed net income attributable to parent    0
Net income (loss) attributable to parent:(95)100(73)(63)(23)
Preferred stock dividends and other adjustments    (2)
Other undisclosed net income available to common stockholders, basic    1
Net income (loss) available to common stockholders, diluted:(95)100(73)(63)(24)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(95)100(73)(63)(23)
Other comprehensive income (loss)1(0)(1)1(1)
Comprehensive income (loss):(94)100(74)(62)(24)
Other undisclosed comprehensive income, net of tax, attributable to parent    0
Comprehensive income (loss), net of tax, attributable to parent:(94)100(74)(62)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: